Upcoming Events
- 2024 started on a lackluster note for venture dealmaking. Deal value for Q1 2024 surfaced a 29.0% decline from the same quarter a year ago.
- Exit value remains low, but recent listings show signs optimism for IPO window to warm up.
- The imbalance of capital demand and supply is being most acutely felt in venture-growth stage investments.
Industry Events Calendar
To submit an event to be considered for the NVCA Events Calendar please click here.
Tell Us About Your Event
"*" indicates required fields
Calendar of Events
M Mon
T Tue
W Wed
T Thu
F Fri
S Sat
S Sun
0 events,
0 events,
2 events,
Cisco – Innovation Unleashed: Navigating Emerging Technologies
Cisco – Innovation Unleashed: Navigating Emerging Technologies
Highlighting perspectives from executive leadership at one of the world's most prominent corporate venture capital firms, Cisco Investments (the venture capital arm of Cisco Systems, Inc.) alongside two best-in-class AI companies, DataRobot and Robust Intelligence. This live webinar delves into the realm of AI, showcasing its vast potential and the transformative impact it can have …
Q1 2024 PitchBook-NVCA Venture Monitor
Q1 2024 PitchBook-NVCA Venture Monitor
Due to a lack of large deals and low capital availability, 2024 is seeing the most investor-friendly venture market in over a decade. While companies return to the market to raise, Q1’s liquidity crunch resulted in only $9.3B venture capital raised across 100 US VC funds. The issue of capital availability continues to put pressure on …
1 event,
2024 NVCA Annual Leadership Gala and Awards Ceremony
We are excited to honor VC industry leaders at the Ritz Carlton Hotel in San Francisco on May 2nd. We are thrilled to announce that registration is now open! Please join us to celebrate the venture industry and honor those who have made significant contributions to foster innovation, advance technology, and drive new company formation.
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
0 events,
1 event,
BioNJ BioPartnering Conference
BioNJ, in partnership with J.P. Morgan, Johnson & Johnson, Morgan Lewis, and Jersey City Economic Development Corporation, are proud to present our 14th Annual BioPartnering Conference where we bring together innovators, investors and biopharmaceutical industry executives with the goal to foster productive partnerships and facilitate investment opportunities. Location: Liberty Science Center in NJ.